The Zygomycetes represent relatively uncommon isolates in the clinical laboratory, reflecting
either environmental contaminants or, less commonly, a clinical disease called …

Mucormycosis is a life-threatening fungal infection that occurs in immunocompromised
patients. These infections are becoming increasingly common, yet survival remains very …

This fully revised and extensively expanded edition aims to illustrate the diversity of fungal
agents. Following introductory chapters on fungal classification, clinical pathology, natural …

Invasive fungal infections are increasingly common in the nosocomial setting. Furthermore,
because risk factors for these infections continue to increase in frequency, it is likely that …

Despite advances in preventive, diagnostic, and therapeutic interventions, invasive fungal
infections cause significant morbidity and mortality in immunocompromised patients. The …

Scedosporium spp. are increasingly recognized as causes of resistant life-threatening
infections in immunocompromised patients. Scedosporium spp. also cause a wide spectrum …

The emergence of less common but medically important fungal pathogens contributes to the
rate of morbidity and mortality, especially in the increasingly expanding population of …

Background. It has been axiomatic that echinocandins (eg, caspofungin) are ineffective
against mucormycosis. However, on the basis of preclinical data, we recently began treating …

The need for safe and effective antifungal agents increases in parallel with the expanding
number of immunocompromised patients at risk for invasive fungal infections. The …

Objectives Echinocandins are the newest addition of the last decade to the antifungal
armamentarium, which, owing to their unique mechanism of action, selectively target the …